Forbes March 28, 2025
The United States led the world in developing the technology that beat the COVID-19 pandemic. Action from lawmakers may leave that legacy—and a $70 billion market—behind.
Less than a year after COVID-19 upended life as we know it and killed the first of what would become more than 7 million people, the FDA and other regulators around the world authorized the first mRNA vaccine. Co-developed by Pfizer and BioNTech, the vaccine was based on new biotechnology that uses the body’s own machinery to produce disease-fighting antibodies. Authorization for a second mRNA vaccine from Moderna followed shortly after. The speed with which they were developed and...
Today's Sponsors
Today's Sponsor
